The indictments alleged that Mr. Philip, the company and three former sales managers committed fraud against surgeons and the FDA while promoting two bone growth products. Mr. Philip was indicted in 2009 and 2011. Charges against the co-defendants were dropped last month.
Related Articles on the Stryker Case:
Feds Drop Charges Against Former Stryker Sales Manager
Stryker Federal Criminal Trial Starts in Boston
Stryker Biotech Indicted for Fraudulent Marketing of Bone Growth Products
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
